Bg pattern

APREPITANT QILU 125 mg HARD CAPSULES

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use APREPITANT QILU 125 mg HARD CAPSULES

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Aprepitant Qilu 125 mg hard capsules EFG

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Aprepitant Qilu and what is it used for
  2. What you need to know before you take Aprepitant Qilu
  3. How to take Aprepitant Qilu
  4. Possible side effects
  5. Storage of Aprepitant Qilu
  6. Contents of the pack and other information

1. What is Aprepitant Qilu and what is it used for

This medicine contains the active substance aprepitant and belongs to a group of medicines called "neurokinin 1 (NK1) receptor antagonists". The brain has a specific area that controls nausea and vomiting. Aprepitant works by blocking the signals in this area, and thus reducing nausea and vomiting. Aprepitant capsules are used in adults and adolescents from 12 years of age, in combination with other medicinesto prevent nausea and vomiting caused by cancer chemotherapy (that induces strong and moderate nausea and vomiting, such as cisplatin, cyclophosphamide, doxorubicin, or epirubicin).

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Aprepitant Qilu

Do not take Aprepitant Qilu

  • if you are allergic to aprepitant or any of the other ingredients of this medicine (listed in section 6).
  • with medicines that contain pimozide (used to treat psychiatric disorders), terfenadine, and astemizole (used for allergic rhinitis and other allergic disorders), cisapride (used to treat digestive problems). Inform your doctor if you are taking these medicines, as treatment should be modified before starting aprepitant.

Warnings and precautions

Consult your doctor, pharmacist, or nurse before starting this medicine.

Before treatment with this medicine, inform your doctor if you have liver disease, as the liver is important for removing the medicine from the body. Therefore, your doctor may need to monitor your liver condition.

Children and adolescents

Do not give this medicine to children under 12 years of age, as 125 mg capsules have not been studied in this population.

Other medicines and Aprepitant Qilu

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

Aprepitant may affect other medicines during and after treatment with aprepitant. There are some medicines that should not be taken with aprepitant (such as pimozide, terfenadine, astemizole, and cisapride) or that require a dose adjustment (see also ‘Do not take Aprepitant Qilu’).

The effects of aprepitant or other medicines may be influenced if you take aprepitant with other medicines, including those listed below. Consult your doctor or pharmacist if you are taking any of the following medicines:

  • contraceptive medicines that may include birth control pills, skin patches, implants, and certain intrauterine devices (IUDs) that release hormones; they may not work properly when taken with this medicine. During treatment with this medicine and up to 2 months after using aprepitant.
  • cyclosporine, tacrolimus, sirolimus, everolimus (immunosuppressants used to prevent organ rejection after a transplant);
  • alfentanil, fentanyl (used to treat pain);
  • quinidine (used to treat irregular heartbeats);
  • irinotecan, etoposide, vinorelbine, ifosfamide (cancer medicines);
  • medicines that contain ergot-derived alkaloids, such as ergotamine or dihydroergotamine (used to treat migraines);
  • warfarin, acenocoumarol (blood thinners; blood tests may be needed);
  • rifampicin, clarithromycin, telithromycin (antibiotics used to treat infections);
  • phenytoin (used to treat seizures);
  • carbamazepine (used to treat depression and epilepsy);
  • midazolam, triazolam, phenobarbital (medicines used to calm or help sleep);
  • St. John's Wort (a herbal preparation used to treat depression);
  • protease inhibitors (used to treat HIV infections);
  • ketoconazole, except shampoo (used to treat Cushing's syndrome - when the body produces too much cortisol);
  • itraconazole, voriconazole, posaconazole (used to treat fungal infections);
  • nefazodone (used to treat depression);
  • corticosteroids (such as dexamethasone and methylprednisolone);
  • anxiety medicines (such as alprazolam);
  • tolbutamide (used to treat diabetes).

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.

This medicine should not be used during pregnancy unless strictly necessary.

For information on birth control, see ‘Using Aprepitant Qilu with other medicines’.

It is not known if this medicine is excreted in breast milk; therefore, breastfeeding should not be done during treatment with this medicine. It is important to inform your doctor before starting this medicine if you are breastfeeding or plan to do so.

Driving and using machines

It should be taken into account that some people have dizziness and drowsiness after taking this medicine. If you feel dizzy or drowsy, avoid driving, cycling, or using machines or tools after taking this medicine (see ‘Possible side effects’).

Aprepitant Qilu contains sucrose

This medicine contains sucrose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.

Aprepitant Qilu contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per capsule; this is essentially ‘sodium-free’.

3. How to take Aprepitant Qilu

Always take this medicine exactly as your doctor, pharmacist, or nurse has told you. If you are not sure, check with your doctor, pharmacist, or nurse.

Take aprepitant always with other medicines to prevent nausea and vomiting. After treatment with this medicine, your doctor may ask you to continue taking other medicines to prevent nausea and vomiting, including corticosteroids (such as dexamethasone) and a ‘5-HT3 antagonist’ (such as ondansetron).

The recommended oral dose of this medicine is:

Day 1:

  • one 125 mg capsule 1 hour before starting the chemotherapy session.

and

Days 2 and 3:

  • one 80 mg capsule each day.

Aprepitant can be taken with or without food.

Swallow the capsule whole with some liquid.

If you take more Aprepitant Qilu than you should

Do not take more capsules than your doctor recommends. If you have taken too many capsules, contact your doctor immediately.

If you forget to take Aprepitant Qilu

If you miss a dose, consult your doctor.

If you have any further questions on the use of this product, ask your doctor, pharmacist, or nurse.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop taking this medicine and contact your doctor immediately if you notice any of the following serious side effects, which may require urgent medical attention:

Frequency not known (cannot be estimated from the available data)

  • Hives, rash, itching, difficulty breathing or swallowing; these are signs of an allergic reaction.

Other side effects that have been reported are listed below.

Common (may affect up to 1 in 10 people):

  • constipation, indigestion
  • headache
  • fatigue
  • loss of appetite
  • hiccups
  • increase in liver enzymes in the blood.

Uncommon (may affect up to 1 in 100 people):

  • dizziness, drowsiness
  • acne, rash
  • anxiety
  • belching, nausea, vomiting, heartburn, stomach pain, dry mouth, flatulence
  • increased painful or burning urination
  • weakness, general feeling of being unwell
  • flushing or redness of the face or skin
  • rapid or irregular heartbeat
  • fever with a high risk of infection, decrease in red blood cells.

Rare (may affect up to 1 in 1,000 people):

  • difficulty thinking, lack of energy, altered taste
  • skin sensitivity to sunlight, excessive sweating, oily skin, skin ulcers, itchy rash, Stevens-Johnson syndrome/toxic epidermal necrolysis (rare severe skin reactions)
  • euphoria (extreme feeling of happiness), disorientation
  • bacterial infection, fungal infection
  • severe constipation, stomach ulcers, inflammation of the small intestine and colon, mouth ulcers, abdominal distension
  • frequent urination, urinating more than usual, presence of sugar or blood in the urine
  • chest discomfort, swelling, changes in walking
  • cough, mucous in the back of the throat, throat irritation, sneezing, sore throat
  • eye discharge or itching
  • ringing in the ears
  • muscle spasms, muscle weakness
  • excessive thirst
  • slow heartbeat, blood vessel and vein problems
  • decrease in white blood cells, low sodium levels in the blood, weight loss.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Vigilance System for Human Use: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Aprepitant Qilu

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of the month.

This medicine does not require any special storage conditions.

Store in the original package to protect from moisture.

Do not remove the capsule from the blister until the moment of intake.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

Composition of Aprepitant Qilu

  • The active substance is aprepitant. Each 125 mg hard capsule contains 125 mg of aprepitant.
  • The other ingredients are: hypromellose, sodium lauryl sulfate, sucrose (see section 2, “Aprepitant Qilu contains sucrose”), microcrystalline cellulose, talc, gelatin, titanium dioxide (E 171), red iron oxide (E 172), lacquer, potassium hydroxide, black iron oxide (E 172).

Appearance and packaging

The 125 mg hard capsule is a size 1 opaque capsule with a white body and a pink cap with “30” and “125 mg” printed radially in black ink on the body.

Aprepitant 125 mg hard capsules are available in the following pack sizes:

  • 1 aluminum blister containing one 125 mg capsule.
  • 5 aluminum blisters, each containing one 125 mg capsule.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

QILU PHARMA SPAIN S.L.

Paseo De La Castellana 40

8th floor, 28046 - Madrid

Spain

Manufacturer

KYMOS, S.L.

Ronda de Can Fatjó 7b, Parc Tecnológic el Vallès

Cerdanyola del Vallès, 08290,

Spain

Netpharmalab consulting services

Carretera de Fuencarral 22

Alcobendas, 28108 Madrid

Spain

This medicine is authorized in the Member States of the European Economic Area under the following names:

ES (RMS)

Aprepitant Qilu 125 mg hard capsules EFG

DE

Aprepitant Qilu 125 mg Hartkapseln

FR

Aprepitant Qilu 125 mg gélules

IT

Aprepitant Qilu

Date of last revision of this leaflet:September 2020.

Other sources of information

Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for APREPITANT QILU 125 mg HARD CAPSULES

Discuss questions about APREPITANT QILU 125 mg HARD CAPSULES, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80
0.0 (0)
Doctor

Daniel Cichi

Family medicine 24 years exp.

Dr Daniel Cichi is a family medicine doctor with over 20 years of clinical experience. He provides online consultations for adults, supporting patients with acute symptoms, chronic conditions, and everyday health concerns that require timely medical guidance.

His background includes work in emergency care, ambulance services, and family medicine, which allows him to assess symptoms quickly, identify warning signs, and help patients choose the safest next steps – whether that means home care, treatment adjustment, or in-person evaluation.

Patients commonly consult Dr Daniel Cichi for:

  • acute symptoms: fever, infections, flu-like illness, cough, sore throat, shortness of breath;
  • chest discomfort, palpitations, dizziness, fatigue, and blood pressure concerns;
  • digestive problems: abdominal pain, nausea, diarrhoea, constipation, reflux;
  • muscle, joint, and back pain, minor injuries, post-traumatic symptoms;
  • chronic conditions: hypertension, diabetes, high cholesterol, thyroid disorders;
  • review and interpretation of lab tests, imaging reports, and medical documents;
  • medication review and treatment adjustment;
  • medical advice while travelling or living abroad;
  • second opinions and guidance on whether in-person care is needed.
Dr Cichi’s consultations are structured and practical. He focuses on clear explanations, risk assessment, and actionable recommendations, helping patients understand their symptoms and make informed decisions about their health.
Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for APREPITANT QILU 125 mg HARD CAPSULES?
APREPITANT QILU 125 mg HARD CAPSULES requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in APREPITANT QILU 125 mg HARD CAPSULES?
The active ingredient in APREPITANT QILU 125 mg HARD CAPSULES is aprepitant. This information helps identify medicines with the same composition but different brand names.
Who manufactures APREPITANT QILU 125 mg HARD CAPSULES?
APREPITANT QILU 125 mg HARD CAPSULES is manufactured by Qilu Pharma Spain S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of APREPITANT QILU 125 mg HARD CAPSULES online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether APREPITANT QILU 125 mg HARD CAPSULES is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to APREPITANT QILU 125 mg HARD CAPSULES?
Other medicines with the same active substance (aprepitant) include APREPITANT ACCORD 125 mg HARD CAPSULES / APREPITANT ACCORD 80 mg HARD CAPSULES, APREPITANT QILU 125 mg HARD CAPSULES / APREPITANT QILU 80 mg HARD CAPSULES - Generic, APREPITANT QILU 80 mg HARD CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media